| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $386.5M | — | +1.0% |
| Cost of Revenue | $88.8M | — | -10.8% |
| Gross Profit | $297.7M | — | +5.1% |
| R&D Expense | $47.5M | — | +9.4% |
| SG&A Expense | $42.6M | — | +17.0% |
| Operating Income | $63.6M | — | -13.9% |
| Pre-tax Income | $64.0M | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $175.5M | +12.5% | — |
| Accounts Receivable | $345.9M | -13.7% | — |
| Current Assets | $622.7M | -5.2% | — |
| Total Assets | $8.63B | -0.7% | — |
| Current Liabilities | $633.8M | -2.9% | — |
| Total Liabilities | $973.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $115.4M | — | -8.0% |
| Capital Expenditures | $2.4M | — | +57.1% |
| Investing Cash Flow | -$33.1M | — | +27.4% |
| Financing Cash Flow | -$60.8M | — | +19.0% |
| Free Cash Flow | $113.1M | — | -8.8% |
| -14.1% |
| Income Tax | $16.6M | — | +10.9% |
| Net Income | $47.4M | — | -20.3% |
| EPS (Basic) | $0.18 | — | -18.2% |
| EPS (Diluted) | $0.18 | — | -18.2% |
| -4.5% |
| — |
| Stockholders' Equity | $7.66B | -0.2% | -0.2% |